Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenue        
Total revenues $ 112,927 $ 0 $ 169,676 $ 0
Operating costs and expenses:        
Research and development (307,900) (487,519) (667,551) (951,301)
General and administrative (787,486) (890,779) (1,715,366) (1,754,152)
Total operating costs and expenses (1,095,386) (1,378,298) (2,382,917) (2,705,453)
Loss from operations (982,459) (1,378,298) (2,213,241) (2,705,453)
Other income:        
Other income 192 735 58 490
Interest income, net 28,625 163 80,112 313
Total other income 28,817 898 80,170 803
Net loss (953,642) (1,377,400) (2,133,071) (2,704,650)
Deemed dividend 0 0 0 (3,879,447)
Net loss applicable to common stockholders $ (953,642) $ (1,377,400) $ (2,133,071) $ (6,584,097)
Basic and diluted loss per share $ (0.15) $ (1.56) $ (0.34) $ (7.79)
Weighted-average shares of common stock outstanding, basic and diluted 6,288,351 882,107 6,260,841 844,749
Royalty [Member]        
Revenue        
Total revenues $ 112,927 $ 0 $ 169,676 $ 0